EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



Unmet Needs, Uncommon Commitment: The Shift Toward Investment in Rare Diseases

Tuesday, January 10, 4:45 pm
Hilton San Francisco Union Square

Join biotech leaders, emerging innovators, investors and patient advocacy group representatives for a candid, interactive and enlightening panel discussion about the evolving landscape in rare disease drug discovery and development.  The panel will be followed by a Making RARE Connections panel, sponsored by Shire.  RSVP is required to attend and seats are limited!

Pulse, Prognosis and the Press: A journalist “wrap-up” session and look into Biotech 2017

Wednesday, January 11, 4:30 pm
Hilton San Francisco Union Square

As the intensity of the week winds down, join our exclusive panel of all-star reporters for their unique take on the news, trends and issues that will reverberate in 2017, and beyond.  Get a fresh take on the top newsmakers and analysis of the week's biggest stories heard in Union Square.


TPP Healthcare China Partnering Forum

Sunday, January 8, 8:00 am
Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom 

TPP will host an educational program for Western companies interested in attracting Chinese investors or collaborating with Chinese companies. 

January 9–11, TPP will host Chinese investors seeking investment and licensing opportunities with innovative US companies. Parc 55 San Francisco, Level 3, Embarcadero

To register to participate in Sunday’s education program or to meet with Chinese investors/companies, contact: brianyang@TPPhealthcare.com

Women in Bio Reception

Tuesday, January 10, 6:00 pm
Parc 55 San Francisco, Level 3, Market Street

Plan to attend this exclusive event showcasing Board-Certified executives. For Investors, CEOs, and Board Members looking for biotech executives to serve on their boards. 

By invitation only. Please contact Jamie Strachota, Executive Director at info@womeninbio.org

Australia’s 43.5% R&D Refund Incentive – 101 Session

Tuesday, January 10, 6:30 pm

How Foreign Entities can claim the Australian 43.5% R&D Tax Incentive:  Take advantage of this non-dilutive funding and significantly reduce the cost of your investment in R&D!

Novotech and Deloitte will be hosting a free information session during Biotech Showcase 2017, January 10, 2017, to outline and explain the advantages of conducting clinical trials in Australia/Asia Pacific, and how the lucrative Australian R&D refund scheme works in practice. 

To secure a seat please pre-register here.